|
Gastroenterology
Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
Seo Yeon Yoo, Eunju Kim, Gi-Byoung Nam, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Jonggi Choi
Korean J Intern Med. 2022;37(3):555-566. Published online January 26, 2022
Background/Aims: The safety of direct oral anticoagulants (DOACs) compared with warfarin in patients with both nonvalvular atrial fibrillation (AF) and clinically confirmed liver cirrhosis (LC) has not been well studied. We compared the risk of a major bleeding event between DOAC and warfarin treatm..
|
|
|
Cardiology
A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
Hyeongsoo Kim, Young Soo Lee, Tae-Hoon Kim, Myung-Jin Cha, Jung Myung Lee, Junbeom Park, Jin-Kyu Park, Ki-Woon Kang, Jaemin Shim, Jae-Sun Uhm, Hyung Wook Park, Eue-Keun Choi, Jin-Bae Kim, Changsoo Kim, Jun Kim, Boyoung Joung
Korean J Intern Med. 2020;35(1):99-108. Published online April 25, 2019
Background/Aims: Efforts to reduce stroke in patients with atrial fibrillation (AF) have focused on increasing physician adherence to oral anticoagulant (OAC) guidelines; however, the high early discontinuation rate of vitamin K antagonists (VKAs) is a limitation. Although non-VKA OACs (NOACs) are m..
|
|
|
Pulmonology
Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension
Byung Ju Kang, Yeon-Mok Oh, Sang-Do Lee, Jae Seung Lee
Korean J Intern Med. 2015;30(6):837-845. Published online October 30, 2015
Background/Aims: Idiopathic pulmonary arterial hypertension (IPAH) is an incurable disease with high mortality. Although most studies recommend anticoagulation treatment for IPAH, the benefits are uncertain, particularly in Korea, where it has not been studied. The purpose of this study was to evalu..
|
|
|
Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome
Hayne Cho Park, Hyun-Bae Yoon, Tae Woo Lee, Ji Yong Jung, Ho Jun Chin, Yon Su Kim, Suhnggwon Kim
Korean J Intern Med. 2012;27(2):232-234. Published online May 31, 2012
|
|
|
Endoscopic Treatment of Dieulafoy Lesions and Risk Factors for Rebleeding
Won Lim, Tae Oh Kim, Su Bum Park, Ha Rin Rhee, Jin Hyun Park, Jung Ho Bae, Hong Ryeul Jung, Mi Ra Kim, NaRiA Lee, Sun Mi Lee, Gwang Ha Kim, Jeong Heo, Geun Am Song
Korean J Intern Med. 2009;24(4):318-322. Published online November 27, 2009
Background/AimsDieulafoy lesions are an important cause of upper gastrointestinal bleeding. The purpose of this study was to assess the efficacy of endoscopic treatment for these lesions and to identify the possible predictive factors for rebleeding associated with clinical an..
|
|
|
